Aldeídia Pereira de Oliveira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Aldeídia Pereira de Oliveira has a total of 321 co-authors. Here are the top co-authors by number of shared publications:
- Lucindo J. Quintans-Júnior
Laboratory of Neuroscience and Pharmacological Assays, Federal University of Sergipe, São Cristóvão, SE, Brazil
12 shared publications - Daniel Dias Rufino Arcanjo
Universidade Federal do Piauí
9 shared publications - Jackson Roberto Guedes da Silva Almeida
Universidade Federal do Vale do São Francisco, Brasil
5 shared publications Rita de Cássia Meneses Oliveira
Medicinal Plants Research Center-PI, Terezina, Piauí, Brazil
5 shared publicationsCarla Kelly Barroso Sabino
Medicinal Plants Research Center-PI, Terezina, Piauí, Brazil
4 shared publications- Rita de Cássia Meneses Oliveira
Northeast Biotechnology Network - RENORBIO, Federal University of Piauí - UFPI, Teresina, Brazil
4 shared publications
Latest Publications
- 7 January 2026
- Published by Elsevier in South African Journal of Botany
- Vol. 189, 590-603
Chemical characterization, toxicity and involvement of calmodulin in the antithrombotic activity of Rosmarinus officinalis L. essential oil
- 7 January 2026
- Published by Elsevier in South African Journal of Botany
- Vol. 189, 590-603
Chemical characterization, toxicity and involvement of calmodulin in the antithrombotic activity of Rosmarinus officinalis L. essential oil
- Open Access
- 25 September 2025
- Published by Universidade Estadual de Maringa in Acta Scientiarum. Biological Sciences
- Vol. 47, e75753
Toxicogenetic evaluation of the ethanolic flower extract of Pityrocarpa moniliformis (Benth.) in preclinical studies
The species Pityrocarpa moniliformis (Benth.), commonly known as angico-de-bezerro or catanduva, is traditionally used in folk medicine for the treatment of prostate inflammation and is known to possess important biological properties, such as antioxidant and antimicrobial activities. However, despite its therapeutic applications, the genotoxicological profile of this species remains poorly understood. This study aims to evaluate the toxicity, cytotoxicity and mutagenic potential of the ethanolic extract of flower of Pityrocarpa moniliformis (Benth.) using the Artemia salina bioassay, MTT assay and Allium cepa L. test. The extract was tested at concentrations ranging from 0.1 to 1000 µg mL-1. The A. salina and MTT assays demonstrated a decrease in cell viability at concentrations starting from 243 µg mL-1. In the A. cepa test, no cytotoxic effects were detected; however, a significant increase in chromosomal alterations was observed at 500, 750 and 1,000 µg mL-1. Our findings, therefore, suggest that the ethanolic flower extract of P. moniliformis exhibits toxicogenetic effects at higher concentrations, necessitating further investigation in preclinical studies.
- 25 September 2025
- Published by Universidade Estadual de Maringa in Acta Scientiarum. Biological Sciences
- Vol. 47, e75753
Open AccessToxicogenetic evaluation of the ethanolic flower extract of Pityrocarpa moniliformis (Benth.) in preclinical studies
The species Pityrocarpa moniliformis (Benth.), commonly known as angico-de-bezerro or catanduva, is traditionally used in folk medicine for the treatment of prostate inflammation and is known to possess important biological properties, such as antioxidant and antimicrobial activities. However, despite its therapeutic applications, the genotoxicological profile of this species remains poorly understood. This study aims to evaluate the toxicity, cytotoxicity and mutagenic potential of the ethanolic extract of flower of Pityrocarpa moniliformis (Benth.) using the Artemia salina bioassay, MTT assay and Allium cepa L. test. The extract was tested at concentrations ranging from 0.1 to 1000 µg mL-1. The A. salina and MTT assays demonstrated a decrease in cell viability at concentrations starting from 243 µg mL-1. In the A. cepa test, no cytotoxic effects were detected; however, a significant increase in chromosomal alterations was observed at 500, 750 and 1,000 µg mL-1. Our findings, therefore, suggest that the ethanolic flower extract of P. moniliformis exhibits toxicogenetic effects at higher concentrations, necessitating further investigation in preclinical studies.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 58, e14598
Comparative analysis of autonomic effects of ketamine-xylazine in normotensive and hypertensive rats
This study aimed to evaluate the effects of the ketamine-xylazine (KX) anesthetic mixture on autonomic and cardiovascular functions in normotensive rats (Wistar) and spontaneously hypertensive rats (SHR), using both spectral and symbolic analyses. Male Wistar (n=22) and SHR (n=28) rats were intramuscularly anesthetized with KX, and their femoral artery and vein were cannulated for pulsatile arterial pressure recording and drug administration. Autonomic function was assessed 24 and 48 h post-surgery through spectral and symbolic analyses of heart rate (HR) and systolic arterial pressure (SAP) variability. KX anesthesia significantly decreased mean arterial pressure (MAP) 24 h post-surgery in both Wistar and SHR rats. Spectral analysis revealed increased sympathetic modulation in the vascular bed of SHR 48 h post-surgery. In Wistar rats, there was a significant reduction in parasympathetic modulation at 48 h, as indicated by root mean square of successive RR interval differences (RMSSD) and high frequency (HF) (nu) indices. Symbolic analysis, however, detected no significant changes in autonomic modulation. These data are consistent with the notion that KX anesthesia significantly impacts autonomic and cardiovascular functions, with differential effects observed between Wistar and SHR rats. Spectral analysis proved more effective than symbolic analysis in detecting these changes. These findings highlight the need for careful consideration of anesthetic effects in experimental research and suggest that optimizing anesthetic protocols could improve clinical outcomes by minimizing adverse autonomic impact.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 58, e14598
Open AccessComparative analysis of autonomic effects of ketamine-xylazine in normotensive and hypertensive rats
This study aimed to evaluate the effects of the ketamine-xylazine (KX) anesthetic mixture on autonomic and cardiovascular functions in normotensive rats (Wistar) and spontaneously hypertensive rats (SHR), using both spectral and symbolic analyses. Male Wistar (n=22) and SHR (n=28) rats were intramuscularly anesthetized with KX, and their femoral artery and vein were cannulated for pulsatile arterial pressure recording and drug administration. Autonomic function was assessed 24 and 48 h post-surgery through spectral and symbolic analyses of heart rate (HR) and systolic arterial pressure (SAP) variability. KX anesthesia significantly decreased mean arterial pressure (MAP) 24 h post-surgery in both Wistar and SHR rats. Spectral analysis revealed increased sympathetic modulation in the vascular bed of SHR 48 h post-surgery. In Wistar rats, there was a significant reduction in parasympathetic modulation at 48 h, as indicated by root mean square of successive RR interval differences (RMSSD) and high frequency (HF) (nu) indices. Symbolic analysis, however, detected no significant changes in autonomic modulation. These data are consistent with the notion that KX anesthesia significantly impacts autonomic and cardiovascular functions, with differential effects observed between Wistar and SHR rats. Spectral analysis proved more effective than symbolic analysis in detecting these changes. These findings highlight the need for careful consideration of anesthetic effects in experimental research and suggest that optimizing anesthetic protocols could improve clinical outcomes by minimizing adverse autonomic impact.
- Open Access
- 28 October 2022
- Published by Universidade Estadual de Maringa in Acta Scientiarum. Biological Sciences
- Vol. 44, e62665
Evaluation of the cytotoxic and mutagenic potential of Rosmarinus officinalis L. essential oil through the Allium cepa Leach bioassay
The species Rosmarinus officinalis L. (rosemary) is an herb from the Lamiaceae family, widely used in cooking as a food preservative, seasoning or condiment. It also stands out for its therapeutic properties, mainly presenting antioxidant, antibacterial and antitumor activity. The aim of this study was to evaluate the cytotoxic and mutagenic activity of R. officinalis L. essential oil through the Allium cepa bioassay. This test constitutes an excellent plant model routinely used due to its sensitivity, low cost and good correlation with test systems in mammals. The defined concentrations for carrying out the test were 750, 243, 81 and 27 µg mL-1. Five bulbs were used, 4 roots of each, measuring approximately 2 cm, and they were analyzed on two slides. All assays were performed at least in triplicate and compared to the negative control. The statistical test of analysis of variance (ANOVA with a fixed factor) was used, followed by Tukey's multiple comparisons test, for p < 0.05. For this purpose, the GraphPad Prism program (version 6.0) was used. The results showed a cytotoxic and mutagenic effect for all concentrations used of the essential oil of R. officinalis L. However, it is important to conduct further research using other genotoxicological tests with different endpoints and at different concentrations, in order to clarify the interaction of the essential oil of the species R. officinalis L. with the genetic material of the cell and its possible mechanism of action.
- 28 October 2022
- Published by Universidade Estadual de Maringa in Acta Scientiarum. Biological Sciences
- Vol. 44, e62665
Open AccessEvaluation of the cytotoxic and mutagenic potential of Rosmarinus officinalis L. essential oil through the Allium cepa Leach bioassay
The species Rosmarinus officinalis L. (rosemary) is an herb from the Lamiaceae family, widely used in cooking as a food preservative, seasoning or condiment. It also stands out for its therapeutic properties, mainly presenting antioxidant, antibacterial and antitumor activity. The aim of this study was to evaluate the cytotoxic and mutagenic activity of R. officinalis L. essential oil through the Allium cepa bioassay. This test constitutes an excellent plant model routinely used due to its sensitivity, low cost and good correlation with test systems in mammals. The defined concentrations for carrying out the test were 750, 243, 81 and 27 µg mL-1. Five bulbs were used, 4 roots of each, measuring approximately 2 cm, and they were analyzed on two slides. All assays were performed at least in triplicate and compared to the negative control. The statistical test of analysis of variance (ANOVA with a fixed factor) was used, followed by Tukey's multiple comparisons test, for p < 0.05. For this purpose, the GraphPad Prism program (version 6.0) was used. The results showed a cytotoxic and mutagenic effect for all concentrations used of the essential oil of R. officinalis L. However, it is important to conduct further research using other genotoxicological tests with different endpoints and at different concentrations, in order to clarify the interaction of the essential oil of the species R. officinalis L. with the genetic material of the cell and its possible mechanism of action.
- 21 April 2021
- Published by Wiley in Acta Physiologica
- Vol. 232 (3) , e13663
Benefits of pharmacological and electrical cholinergic stimulation in hypertension and heart failure
Systemic arterial hypertension and heart failure are cardiovascular diseases that affect millions of individuals worldwide. They are characterized by a change in the autonomic nervous system balance, highlighted by an increase in sympathetic activity associated with a decrease in parasympathetic activity. Most therapeutic approaches seek to treat these diseases by medications that attenuate sympathetic activity. However, there is a growing number of studies demonstrating that the improvement of parasympathetic function, by means of pharmacological or electrical stimulation, can be an effective tool for the treatment of these cardiovascular diseases. Therefore, this review aims to describe the advances reported by experimental and clinical studies that addressed the potential of cholinergic stimulation to prevent autonomic and cardiovascular imbalance in hypertension and heart failure. Overall, the published data reviewed demonstrate that the use of central or peripheral acetylcholinesterase inhibitors is efficient to improve the autonomic imbalance and hemodynamic changes observed in heart failure and hypertension. Of note, the baroreflex and the vagus nerve activation have been shown to be safe and effective approaches to be used as an alternative treatment for these cardiovascular diseases. In conclusion, pharmacological and electrical stimulation of the parasympathetic nervous system has the potential to be used as a therapeutic tool for the treatment of hypertension and heart failure, deserving to be more explored in the clinical setting.
- 21 April 2021
- Published by Wiley in Acta Physiologica
- Vol. 232 (3) , e13663
Benefits of pharmacological and electrical cholinergic stimulation in hypertension and heart failure
Systemic arterial hypertension and heart failure are cardiovascular diseases that affect millions of individuals worldwide. They are characterized by a change in the autonomic nervous system balance, highlighted by an increase in sympathetic activity associated with a decrease in parasympathetic activity. Most therapeutic approaches seek to treat these diseases by medications that attenuate sympathetic activity. However, there is a growing number of studies demonstrating that the improvement of parasympathetic function, by means of pharmacological or electrical stimulation, can be an effective tool for the treatment of these cardiovascular diseases. Therefore, this review aims to describe the advances reported by experimental and clinical studies that addressed the potential of cholinergic stimulation to prevent autonomic and cardiovascular imbalance in hypertension and heart failure. Overall, the published data reviewed demonstrate that the use of central or peripheral acetylcholinesterase inhibitors is efficient to improve the autonomic imbalance and hemodynamic changes observed in heart failure and hypertension. Of note, the baroreflex and the vagus nerve activation have been shown to be safe and effective approaches to be used as an alternative treatment for these cardiovascular diseases. In conclusion, pharmacological and electrical stimulation of the parasympathetic nervous system has the potential to be used as a therapeutic tool for the treatment of hypertension and heart failure, deserving to be more explored in the clinical setting.
- Open Access
In-silico studies of Riparin B in the design of drugs: Physicochemical, pharmacokinetic and pharmacodynamic parameters
The process involved in the research, discovery and development of drugs is characterized by high extensive and complex cost linked to scientific and technological innovations, and it is necessary to study and verify the progress of research carried out in the field that results in patent applications. Aniba riparia (Nees) Mez is a plant species often used for therapeutic purposes, where its pharmacological properties are associated to the presence of alkaloids called riparins. 5 synthetic analog compounds (riparins A, B, C, D, E and F) were developed from natural riparins. These molecules, natural and synthetic, showed several pharmacological activities in tests performed in vitro and in vivo , highlighting the Central Nervous System (CNS). The objective of this work was to evaluate the physical-chemical, pharmacokinetic parameters (absorption, distribution, metabolism, excretion and toxicity) and pharmacodynamic parameters (bioactivity and adverse reactions) of Riparin B by means of in silico computational prediction. Online software such as Pre-ADMET, SwissADME, Molinspiration and PASS on line were used for the analysis. Riparin B fits the characteristics of druglikeness , pharmacokinetic properties appropriate to the predicted patterns and activities within the scope for the treatment of AD, demonstrating a possible potential in the inhibition of AChE. Therefore, in silico results allow us to conclude that riparin B is predicted to be a potential future drug candidate, especially via oral administration, due to its relevant Drug-likeness profile, bioavailability, excellent liposolubility and adequate pharmacokinetics, including at the level of CNS, penetrating the blood-brain barrier.
Open AccessIn-silico studies of Riparin B in the design of drugs: Physicochemical, pharmacokinetic and pharmacodynamic parameters
The process involved in the research, discovery and development of drugs is characterized by high extensive and complex cost linked to scientific and technological innovations, and it is necessary to study and verify the progress of research carried out in the field that results in patent applications. Aniba riparia (Nees) Mez is a plant species often used for therapeutic purposes, where its pharmacological properties are associated to the presence of alkaloids called riparins. 5 synthetic analog compounds (riparins A, B, C, D, E and F) were developed from natural riparins. These molecules, natural and synthetic, showed several pharmacological activities in tests performed in vitro and in vivo , highlighting the Central Nervous System (CNS). The objective of this work was to evaluate the physical-chemical, pharmacokinetic parameters (absorption, distribution, metabolism, excretion and toxicity) and pharmacodynamic parameters (bioactivity and adverse reactions) of Riparin B by means of in silico computational prediction. Online software such as Pre-ADMET, SwissADME, Molinspiration and PASS on line were used for the analysis. Riparin B fits the characteristics of druglikeness , pharmacokinetic properties appropriate to the predicted patterns and activities within the scope for the treatment of AD, demonstrating a possible potential in the inhibition of AChE. Therefore, in silico results allow us to conclude that riparin B is predicted to be a potential future drug candidate, especially via oral administration, due to its relevant Drug-likeness profile, bioavailability, excellent liposolubility and adequate pharmacokinetics, including at the level of CNS, penetrating the blood-brain barrier.
- 9 April 2020
- Published by Atena Editora Edição de Livros Ltda
- p. 142-158
AÇÕES TOXICOLÓGICAS DOS ADITIVOS ALIMENTARES NO SISTEMA CARDIOVASCULAR
- 9 April 2020
- Published by Atena Editora Edição de Livros Ltda
- p. 142-158
AÇÕES TOXICOLÓGICAS DOS ADITIVOS ALIMENTARES NO SISTEMA CARDIOVASCULAR
- 1 January 2020
- Published by Sociedade Brasileira de Quimica (SBQ) in Journal of the Brazilian Chemical Society
- Vol. 31 (5) , 1064-1077
Theoretical and Experimental Investigations on Inclusion Complex β-Cyclodextrin and Sulcatone: A Cardiovascular Activity Evaluation
- 1 January 2020
- Published by Sociedade Brasileira de Quimica (SBQ) in Journal of the Brazilian Chemical Society
- Vol. 31 (5) , 1064-1077
Theoretical and Experimental Investigations on Inclusion Complex β-Cyclodextrin and Sulcatone: A Cardiovascular Activity Evaluation
- 1 January 2020
- Published by Elsevier in Life Sciences
- Vol. 241, 117102
Naringenin complexed with hydroxypropyl-β-cyclodextrin improves the sciatic nerve regeneration through inhibition of p75NTR and JNK pathway
- 1 January 2020
- Published by Elsevier in Life Sciences
- Vol. 241, 117102
Naringenin complexed with hydroxypropyl-β-cyclodextrin improves the sciatic nerve regeneration through inhibition of p75NTR and JNK pathway
- 24 May 2019
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 64 (11) , 3104-3114
Involvement of Potassium Channels, Nitric Oxide Synthase, and Guanylate Cyclase in the Spasmolytic Effect of Simaba ferruginea A.St.-Hil on Rat Isolated Ileum
Simaba ferruginea A.St.-Hil. Popularly known as “calunga,” is a typical Brazilian cerrado plant whose rhizomes are popular for treating diarrhea.
- 24 May 2019
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 64 (11) , 3104-3114
Involvement of Potassium Channels, Nitric Oxide Synthase, and Guanylate Cyclase in the Spasmolytic Effect of Simaba ferruginea A.St.-Hil on Rat Isolated Ileum
Simaba ferruginea A.St.-Hil. Popularly known as “calunga,” is a typical Brazilian cerrado plant whose rhizomes are popular for treating diarrhea.